| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$26,854 ) |
| | 2023 | 2018 | NUPROBE USA INC | 2575 W BELLFORT AVE | HOUSTON | TX | 77054-5025 | HARRIS | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 000 | 1 | NIH | 3/9/2023 | -$26,854 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | NUPROBE USA, INC. | 2575 W BELLFORT AVE STE 200 | HOUSTON | TX | 77054-5025 | HARRIS | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 001 | 3 | NIH | 7/26/2021 | $0 |
| | 2021 | 2018 | NUPROBE USA, INC. | 2575 W BELLFORT AVE STE 200 | HOUSTON | TX | 77054-5025 | HARRIS | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 000 | 1 | NIH | 7/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $254,960 ) |
| | 2020 | 2020 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 001 | 3 | NIH | 8/21/2020 | $254,960 |
| | 2020 | 2019 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R43CA236103 | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | 000 | 1 | NIH | 7/29/2020 | $0 |
| | 2020 | 2019 | Nuprobe Usa, Inc. | 85 Bolton St | Cambridge | MA | 02140-3366 | MIDDLESEX | USA | R43IP001131 | A highly multiplexed convection flow RT-qPCR assay for rapid and | 02 | 1 | CDC | 8/26/2020 | $0 |
| | 2020 | 2019 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 000 | 2 | NIH | 11/6/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,241,643 ) |
| | 2019 | 2019 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 001 | 2 | NIH | 8/29/2019 | $716,643 |
| | 2019 | 2019 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R43CA236103 | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | 000 | 1 | NIH | 5/13/2019 | $300,000 |
| | 2019 | 2019 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R43CA236103 | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | 001 | 1 | NIH | 8/27/2019 | $0 |
| | 2019 | 2019 | Nuprobe Usa, Inc. | 85 Bolton St | Cambridge | MA | 02140-3366 | MIDDLESEX | USA | R43IP001131 | A highly multiplexed convection flow RT-qPCR assay for rapid and | 01 | 1 | CDC | 8/19/2019 | $0 |
| | 2019 | 2019 | Nuprobe Usa, Inc. | 85 Bolton St | Cambridge | MA | 02140-3366 | MIDDLESEX | USA | R43IP001131 | A highly multiplexed convection flow RT-qPCR assay for rapid and | 00 | 1 | CDC | 7/29/2019 | $225,000 |
| | 2019 | 2018 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 000 | 1 | NIH | 1/9/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $749,300 ) |
| | 2018 | 2018 | NUPROBE USA, INC. | 85 BOLTON ST | CAMBRIDGE | MA | 02140-3366 | MIDDLESEX | USA | R44AG061957 | Rapid, Simple and Cost-Effective Detection of Human Cell Line Contamination | 000 | 1 | NIH | 9/17/2018 | $749,300 |
|
|
